AstraZeneca uses PyTorch and Azure ML to speed up drug discovery September 30, 2020 by admin Tweet The firm has introduced a new production use case for early drug discovery, utilizing the PyTorch framework alongside Microsoft’s Azure Machine Learning to support the latest research. Read more… Neowin Related Posts:Meta announces the launch of the PyTorch FoundationMeta expands use of AWS to support new acquisitionsFTC imposes $1.5M fine on drug discount firm for…Microsoft's ND H100 v5 VM is generally available,…Microsoft will end TLS 1.0 and 1.1 support for Azure…
